D-Trehalose
CAS No. 99-20-7
D-Trehalose( Trehalose | NSC 2093 | NSC-2093 | NSC2093 )
Catalog No. M19301 CAS No. 99-20-7
D-Trehalose can inhibit the decomposition of collagen, so it can be used to improve osteoporosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 37 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameD-Trehalose
-
NoteResearch use only, not for human use.
-
Brief DescriptionD-Trehalose can inhibit the decomposition of collagen, so it can be used to improve osteoporosis.
-
DescriptionTrehalose prevents sciatic nerve damage to and apoptosis of Schwann cells of streptozotocin-induced diabetic C57BL/6J mice.
-
In Vitro——
-
In Vivo——
-
SynonymsTrehalose | NSC 2093 | NSC-2093 | NSC2093
-
PathwayCell Cycle/DNA Damage
-
TargetDNA/RNA Synthesis
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number99-20-7
-
Formula Weight342.29
-
Molecular FormulaC12H22O11
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 250 mg/mL (730.35 mM)
-
SMILESC(C1C(C(C(C(O1)OC2C(C(C(C(O2)CO)O)O)O)O)O)O)O
-
Chemical Namealpha-D-Glucopyranoside, alpha-D-glucopyranosyl
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Actinomycin D
A chemotherapy agent that has the ability to inhibit transcription.
-
GSK-3484862
Gsk-3484862 is a non covalent inhibitor of DNA methyltransferase DNMT1 with anticancer activity. Gsk-3484862 mediates the global demethylation of mouse embryonic stem cells.
-
BRD32048
BRD32048 is a top candidate ETV1 perturbagen. BRD32048 inhibits p300-dependent acetylation of ETV1, thereby promoting its degradation.
Cart
sales@molnova.com